ACAD · Stage, GEX levels and seasonality

Acadia Pharmaceuticals Inc. (ACAD)

Last close $19.58 (-0.36%) on 2026-10-08

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Weinstein stage

Stage 3B — Topping · 1 weeks in this stage · 30-week average $23.86

Stage 3 (topping): the advance stalls and the 30-week average flattens.

What would change it: Stage 4 begins on a weekly close below 19.32 (the top's support) under a flat or falling 30-week SMA.

GEX levels

Put wall	Gamma flip	Call wall
20	20.63	21

Set before the open on 2026-10-06. Members see today's levels, updated every 15 minutes. How to read GEX.

Seasonality

Month	Average return	Months up	Years
January	+0.57%	50%	4
February	+0.07%	50%	4
March	-15.4%	0%	4
April	+0.34%	25%	4
May	+11.82%	50%	4
June	+5.49%	50%	4
July	+10.24%	75%	4
August	+2.33%	75%	4
September	-19.71%	0%	4
October (this month)	+5.9%	67%	3
November	+4.8%	67%	3
December	+18.78%	100%	3

Based on up to 4 years of weekly closes. Past seasonality does not predict future returns.

On Signa plans

The Signa score and Action Card for ACAD, live options flow, dark pool prints, today's GEX levels with vanna and charm, and what 40+ AI agents say about it.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Questions about ACAD

What Weinstein stage is ACAD in?

ACAD is in Stage 3B — Topping, for 1 weeks, based on completed weekly bars and its 30-week moving average (23.86).

How has ACAD done in October?

Over the last 3 years, ACAD averaged +5.9% in October and rose in 67% of them. Past seasonality does not predict future returns.

What are ACAD's GEX levels?

Before the open on 2026-10-06, ACAD's put wall was 20, gamma flip 20.63 and call wall 21. Signa members see today's levels, updated every 15 minutes.

Educational content only, not financial advice. Trading involves substantial risk.